Jacobs Levy Equity Management Inc. lowered its position in MaxLinear, Inc. (NASDAQ:MXL - Free Report) by 94.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 65,808 shares of the semiconductor company's stock after selling 1,023,257 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 0.08% of MaxLinear worth $1,302,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Barclays PLC boosted its stake in MaxLinear by 47.6% during the third quarter. Barclays PLC now owns 335,804 shares of the semiconductor company's stock worth $4,860,000 after buying an additional 108,346 shares during the period. Assenagon Asset Management S.A. boosted its stake in MaxLinear by 339.9% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,250,769 shares of the semiconductor company's stock worth $24,740,000 after buying an additional 966,468 shares during the period. Pacer Advisors Inc. boosted its stake in MaxLinear by 29.0% during the fourth quarter. Pacer Advisors Inc. now owns 1,968 shares of the semiconductor company's stock worth $39,000 after buying an additional 443 shares during the period. R Squared Ltd purchased a new position in MaxLinear during the fourth quarter worth about $45,000. Finally, Vaughan Nelson Investment Management L.P. boosted its stake in MaxLinear by 10.0% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 1,268,857 shares of the semiconductor company's stock worth $25,098,000 after buying an additional 115,867 shares during the period. Hedge funds and other institutional investors own 90.79% of the company's stock.
MaxLinear Stock Down 0.4%
NASDAQ:MXL traded down $0.05 during mid-day trading on Thursday, hitting $11.52. The stock had a trading volume of 198,152 shares, compared to its average volume of 1,437,926. The stock has a 50-day simple moving average of $11.15 and a two-hundred day simple moving average of $15.37. The company has a market capitalization of $975.32 million, a PE ratio of -3.93 and a beta of 1.66. MaxLinear, Inc. has a twelve month low of $8.35 and a twelve month high of $26.59. The company has a current ratio of 1.77, a quick ratio of 1.28 and a debt-to-equity ratio of 0.24.
MaxLinear (NASDAQ:MXL - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The semiconductor company reported ($0.05) earnings per share for the quarter, meeting the consensus estimate of ($0.05). The firm had revenue of $95.93 million for the quarter, compared to analysts' expectations of $95.32 million. MaxLinear had a negative net margin of 68.01% and a negative return on equity of 21.94%. The firm's revenue was up .7% compared to the same quarter last year. During the same quarter last year, the company earned ($0.21) earnings per share. On average, equities research analysts anticipate that MaxLinear, Inc. will post -0.37 EPS for the current year.
Insider Activity at MaxLinear
In other MaxLinear news, Director Ted L. Tewksbury III sold 6,071 shares of the firm's stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $10.40, for a total transaction of $63,138.40. Following the sale, the director now owns 74,995 shares of the company's stock, valued at approximately $779,948. This trade represents a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 7.80% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on MXL shares. Roth Capital set a $11.00 target price on shares of MaxLinear and gave the stock a "neutral" rating in a research note on Thursday, April 24th. Benchmark reaffirmed a "buy" rating and set a $20.00 target price on shares of MaxLinear in a research note on Thursday, April 24th. Susquehanna reduced their price target on shares of MaxLinear from $25.00 to $23.00 and set a "neutral" rating on the stock in a research report on Thursday, January 30th. Stifel Nicolaus reduced their price target on shares of MaxLinear from $26.00 to $16.00 and set a "buy" rating on the stock in a research report on Thursday, April 17th. Finally, Needham & Company LLC reissued a "hold" rating on shares of MaxLinear in a research report on Thursday, January 30th. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, MaxLinear currently has a consensus rating of "Hold" and an average price target of $19.06.
Read Our Latest Stock Analysis on MaxLinear
MaxLinear Company Profile
(
Free Report)
MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.
Recommended Stories

Before you consider MaxLinear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MaxLinear wasn't on the list.
While MaxLinear currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.